ARCHIVES

Navelbine+Herceptin: 78% Response In Breast Cancer

This article is from The Cancer Letter archive.

Vol. 25 No. 11 | November 29, 2002

Download PDF Visit The Full Archive

Related Articles

In Brief: Three Centers Win Comprehensive Designation; Hiatt Named Deputy Director, NCI Cancer Control

October 31, 1997

The Lancet Oncology Issues “Expression Of Concern” Over Paper

July 23, 2010

OPR Reinstates Duke Medical Center’s License To Conduct Human Studies

May 28, 1999

Interview: Von Eschenbach Says His Goal Is to Speed Development of Interventions

March 29, 2002

The White House: Justice Department May Sue Tobacco Firms, Clinton Says

January 22, 1999

Cooperative Groups Fight Back: Members Seek Move To Multidisciplinary Approach, More Funds

May 30, 1975